Trial intelligence / Profile preview

Quetiapine for Social Phobia Cue Reactivity

NCT00407199Phase 4Completed

Sponsor
University of Minnesota
Start
Dec 2006
Primary completion
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of quetiapine in Social Anxiety Disorder (SAD), sponsored by University of Minnesota. Started Dec 2006; status: completed.

02

Drugs

quetiapine
03

Conditions

Social Anxiety Disorder (SAD)

Beyond the preview

Go deeper on NCT00407199.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00407199.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call